Spinogenix
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1801 Century Park E Ste 2400, Los Angele...Website
www.spinogenix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Spinogenix
Spinogenix is a clinical stage biopharmaceutical company developing innovative therapies that restore brain synapses to treat neurological and psychiatric conditions. Its research focuses on regenerative small molecule drugs aimed at improving cognitive and motor function in diseases such as Alzheimers, ALS, schizophrenia, and related disorders.Explore more
Spinogenix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spinogenix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Spinogenix recently announced quarterly report
Check if Spinogenix has recently received funding, and reach out quickly before it becomes old news!
Spinogenix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Spinogenix launches new products
Funding: Get notified immidiatlly once Spinogenix has new funding data
Check out if Spinogenix is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Spinogenix had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Spinogenix
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Spinogenix
Compare insights from companies similar to Spinogenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spinogenix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Spinogenix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Spinogenix.
Spinogenix financials insights
Gather financial insights about Spinogenix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Private Equity
$10.6M
Spinogenix Tech Stack
A closer look at the technologies used by Spinogenix
See more technologies
Spinogenix News & Media
Spinogenix to Present Preclinical Results at ARVO 2026 Demonstrating Neuroprotective Effects of Tazbentetol in Glaucoma and Diabetic Retinopathy Models
New Preclinical Data Show Tazbentetol Reduces Retinal Cell Loss and Preserves Visual Function in Glaucoma and Diabetic Retinopathy Models LOS ANGELES, May 3, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed...Spinogenix Announces CLARITY: a Phase 2b/3 trial of SPG601 for the Treatment of Fragile X Syndrome
LOS ANGELES, April 23, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, is initiating CLARITY, a Phase 2b/3 adaptive trial evaluating SPG601 in male...New Peer-Reviewed Research Demonstrates Neurophysiological Efficacy of Spinogenix's SPG601 in Patients with Fragile X Syndrome
Study Results, Published in Nature Scientific Reports, Found SPG601 Reduced Signature Changes in High-Frequency Gamma Band Activity and Improved Cognition in FXS Patients LOS ANGELES, April 9, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering...Spinogenix Reports Early Improvements in Phase 2 Trial of Tazbentetol in Patients with Schizophrenia at the Schizophrenia International Research Society (SIRS) 2026 Annual Congress
First-in-Class Synaptic Regenerative Therapy Demonstrates Favorable Safety Profile and Early Potential to Improve Symptoms of Schizophrenia LOS ANGELES, March 26, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spinogenix
Sign Up For FreeTo access detailed company insights
Spinogenix is a clinical stage biopharmaceutical company developing innovative therapies that restore brain synapses to treat neurological and psychiatric conditions. Its research focuses on regenerative small molecule drugs aimed at improving cognitive and motor function in diseases such as Alzheimers, ALS, schizophrenia, and related disorders.... Read More
